Targeting mutant p53 in cancer: a long road to precision therapy.
about
Combining Oncolytic Virotherapy with p53 Tumor Suppressor Gene TherapySystems Pharmacology-Based Discovery of Natural Products for Precision Oncology Through Targeting Cancer Mutated Genes.Molecularly targeted therapies in cancer: a guide for the nuclear medicine physician.Stathmin is overexpressed and regulated by mutant p53 in oral squamous cell carcinoma.Development of a genetic sensor that eliminates p53 deficient cells.The oncogenic role of circPVT1 in head and neck squamous cell carcinoma is mediated through the mutant p53/YAP/TEAD transcription-competent complex.Histone Deacetylase Inhibitor-Induced Autophagy in Tumor Cells: Implications for p53.Mechanical cues control mutant p53 stability through a mevalonate-RhoA axis.Insulin Receptor Isoforms in Physiology and Disease: An Updated View.Proteomic identification of ERP29 as a key chemoresistant factor activated by the aggregating p53 mutant Arg282Trp.Biology and evolution of poorly differentiated neuroendocrine tumors.Prognostic and histogenetic roles of gene alteration and the expression of key potentially actionable targets in salivary duct carcinomas.Germline TP53 mutations result into a constitutive defect of p53 DNA binding and transcriptional response to DNA damage.Inhibition of cell proliferation and migration through nucleobase-modified polyamidoamine-mediated p53 delivery.Complexes formed by mutant p53 and their roles in breast cancer.Good Guy or Bad Guy? The Duality of Wild-Type p53 in Hormone-Dependent Breast Cancer Origin, Treatment, and Recurrence.Gain-of-Function (GOF) Mutant p53 as Actionable Therapeutic Target.Natural products targeting the p53-MDM2 pathway and mutant p53: Recent advances and implications in cancer medicineWild-type p53 oligomerizes more efficiently than p53 hot-spot mutants and overcomes mutant p53 gain-of-function via a "dominant-positive" mechanism
P2860
Q33633277-C58BD3E9-8192-4124-869E-9BC425475338Q37708902-98F59152-00FF-4A25-906C-F724167F89E7Q39233197-12D47CBF-F62E-44B1-B3C8-693A7C3C96E8Q41392133-BC0C4CBE-2C88-4A8E-AAAF-FD697AA812EBQ44696790-CA2391AB-0EFF-432B-B79E-1D7E64583135Q47097104-A24A69BA-CAE6-404D-A3F0-3CA6DC846AEDQ47136872-4D3705AF-D7A6-4B11-926E-31F5F9EC77A3Q47236792-04B2AA8D-E240-48D5-8E79-87D64FF5066DQ47668280-6896DB3E-6B25-45EE-84A1-3887D1A3C81DQ48112435-C2E50BEF-1635-4766-BCAA-D20987DF1A34Q48320507-61EBB5CA-5BA7-4A60-B6FA-8AA53E1D8EF8Q49688722-CA8B7D8A-C029-496C-8EEC-5DD5C69AC076Q51441565-3E7BEA79-455C-4139-8EAB-78ACB09B9BAEQ52725109-5E5C1A49-95FD-4198-A2CF-70D3A098E1D9Q55333537-BEDA3ECA-2EFC-4AC2-8276-608B9C62B246Q55515610-C4CC26F4-C22E-455F-A441-C4C167F2C04FQ55515721-A10BA40F-079D-49F9-A361-5584A0D57C4EQ57496075-ED4D60FB-7E3E-4B48-8E71-9E16759929BCQ58789576-1BE040EB-9D9D-44AF-AEDE-C60B69051A2C
P2860
Targeting mutant p53 in cancer: a long road to precision therapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Targeting mutant p53 in cancer: a long road to precision therapy.
@en
type
label
Targeting mutant p53 in cancer: a long road to precision therapy.
@en
prefLabel
Targeting mutant p53 in cancer: a long road to precision therapy.
@en
P2860
P356
P1433
P1476
Targeting mutant p53 in cancer: a long road to precision therapy
@en
P2093
Fiamma Mantovani
Giannino Del Sal
P2860
P304
P356
10.1111/FEBS.13948
P407
P577
2016-11-20T00:00:00Z